Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe
Spotlight

Alaska Proposes Significant Pharmacy Reimbursement Changes

Impacted drugs include physician-dispensed and repackaged drugs, topicals, compounds, and OTC medications.
Read More →
August 17, 2026
Spotlight

Tennessee to Require AI Disclosure in Litigation Filings

Any litigant, party, or attorney who files any pleading, motion, brief, or other document to the Board, must include a disclosure statement.
Read More →
August 17, 2026
Spotlight

VA Launches Psilocybin Trial for Veterans with Treatment-Resistant Depression

In addition to this trial, VA is involved in 20 active clinical trials focused on psychedelic therapies for mental health conditions.
Read More →
August 17, 2026

Illinois Enacts New UR and IME Requirements

Employers, payers, and utilization review organizations must comply with these new requirements.
Read More →
August 17, 2026

Massachusetts Introduces Extreme Temperature Protection Bill

The bill contains measures for temperatures below 60 degrees Fahrenheit, and above 90 degrees Fahrenheit.
Read More →
August 17, 2026

Colorado Study Evaluates Cannabis Reimbursement in Workers’ Comp

Among many aspects, the program involved a specialized medical cannabis physician who managed dosing, titration, and cannabinoid ratios.
Read More →
August 10, 2026

CMS Proposes 2027 Medicare Physician Fee Schedule Updates

Proposed changes would impact reimbursement for telehealth, evaluation and management, and more.
Read More →
August 10, 2026

Arizona Proposes $300 Topical Prescription Cap

The cap is for a 30-day supply. If actual acquisition cost exceeds $300, reimbursement would be limited to 120% of documented AAC.
Read More →
August 10, 2026

California Publishes Study on Cumulative Trauma Claims

CT claims nearly doubled from 9.1% of claims to 16.5% from 2018-2025, with these claims increasing across all regions, demographics, and tenures.
Read More →
August 10, 2026
1 2 3 … 60

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.
Read More

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.
Read More

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2026!

Visit Healthe at Booth #415 to chat and pick up a copy of RxInformer magazine, or sit in on our panel discussion.
Read More

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.
Read More

Emerging Therapies: Phase 3 Data for LSD-Based Drug in Major Depression

Patients taking DT120 for major depressive disorder experienced significant drops in depression symptoms.
Read More

Healthesystems at WCI 2026

Visit Healthe at Booth #921, and don’t forget to check out two educational sessions featuring Healthe leaders!
Read More
1 2 3 … 52
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle